Home » Topics » Regulatory

Regulatory
RSS

CPMP issues positive opinion regarding MabThera for treatment of aggressive NHL

Oct. 22, 2001

Once-daily Adderall XR approved by FDA for ADHD; registration trial discussed at CNS meeting

Oct. 19, 2001

First approval granted for Spiriva in The Netherlands for treatment of COPD

Oct. 19, 2001

FDA advisory committee decision on Diovan for heart failure indication

Oct. 19, 2001

FDA clears use of Allergan's Tazorac cream for treatment of acne

Oct. 18, 2001

GSK seeks European approval of Seretide for COPD

Oct. 18, 2001

Foradil now cleared for use in COPD in the U.S.

Oct. 17, 2001

Health Canada approves enhanced labeling for Copaxone

Oct. 17, 2001

ODAC meeting rescheduled for early December

Oct. 17, 2001

FDA issues approvable letter for UroXatral

Oct. 15, 2001

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...